Unicycive Therapeutics annual total assets
2020
2021
2022
2023
2024
2025
Unicycive Therapeutics Total Assets Growth & History (UNCY)
Unicycive Therapeutics's total assets was $49.1M for fiscal 2025.
View full Unicycive Therapeutics company overviewUnicycive Therapeutics annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $49.1M | $17.5M | +55.16% |
| 2024 | 2024-12-31 | $31.7M | $17.5M | +123.16% |
| 2023 | 2023-12-31 | $14.2M | $11.4M | +403.58% |
| 2022 | 2022-12-31 | $2.8M | −$15.9M | −84.97% |
| 2021 | 2021-12-31 | $18.7M | $18.5M | +9088.24% |
| 2020 | 2020-12-31 | $204,000 | — | — |
Unicycive Therapeutics quarterly total assets
Q4.20
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $72.0M | $42.0M | +140.14% |
| Q1 2026 | 2026-03-31 | $64.4M | $36.5M | +130.46% |
| Q4 2025 | 2025-12-31 | $49.1M | $17.5M | +55.16% |
| Q3 2025 | 2025-09-30 | $50.6M | $12.0M | +31.20% |
| Q2 2025 | 2025-06-30 | $30.0M | −$14.7M | −32.90% |
| Q1 2025 | 2025-03-31 | $27.9M | −$24.4M | −46.65% |
| Q4 2024 | 2024-12-31 | $31.7M | $17.5M | +123.16% |
| Q3 2024 | 2024-09-30 | $38.6M | $19.1M | +98.41% |
| Q2 2024 | 2024-06-30 | $44.7M | $21.8M | +95.35% |
| Q1 2024 | 2024-03-31 | $52.4M | $25.2M | +92.58% |
| Q4 2023 | 2023-12-31 | $14.2M | $11.4M | +403.58% |
| Q3 2023 | 2023-09-30 | $19.4M | $9.3M | +91.04% |
| Q2 2023 | 2023-06-30 | $22.9M | $10.1M | +78.55% |
| Q1 2023 | 2023-03-31 | $27.2M | $11.4M | +72.60% |
| Q4 2022 | 2022-12-31 | $2.8M | −$15.9M | −84.97% |
| Q3 2022 | 2022-09-30 | $10.2M | −$9.6M | −48.55% |
| Q2 2022 | 2022-06-30 | $12.8M | $11.9M | +1303.72% |
| Q1 2022 | 2022-03-31 | $15.8M | — | — |
| Q4 2021 | 2021-12-31 | $18.7M | $18.5M | +9088.24% |
| Q3 2021 | 2021-09-30 | $19.8M | — | — |
| Q2 2021 | 2021-06-30 | $913,000 | — | — |
| Q4 2020 | 2020-12-31 | $204,000 | — | — |
Unicycive Therapeutics total assets trends
Over the last five fiscal years, Unicycive Therapeutics's total assets increased from $204,000 to $49.1M, a change of $48.9M. The latest reported quarter, Q2 2026, shows $72.0M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Unicycive Therapeutics source filings ↗